Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models - Top-Institutions - MDSpire

Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models

  • By

  • Kunyuan He

  • Shaofeng Yang

  • Ke Zhang

  • Ling Yang

  • Fei Song

  • May 25, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Oncology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #5

    Cedars-Sinai Medical Center
    Cedars-Sinai Medical Center

    Los Angeles, California

    Key Differentiators

    • Oncology

Original Source(s)

Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models

  • by Kunyuan He, Shaofeng Yang, Ke Zhang, Ling Yang, Fei Song

  • May 25, 2026

Related Content

Diagnostic value of multimodal ultrasound imaging in triple-negative breast cancer

Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years

Correction: Regulatory actions of LH and follicle-stimulating hormone on breast cancer cells and mammary tumors in rats